Angioedema in the emergency department: a practical guide to differential diagnosis and management

被引：87
作者：
Bernstein J.A. [1 ]
Cremonesi P. [2 ]
Hoffmann T.K. [3 ]
Hollingsworth J. [4 ]
机构：
[1] Division of Immunology/Allergy, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, 45267, OH
[2] Department of Emergency Medicine, E. O. Galliera Hospital, Genoa
[3] Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm
[4] Department of Emergency Medicine, University Hospital, Aintree, Liverpool
来源：
International Journal of Emergency Medicine | 2017年 / 10卷 / 1期
关键词：
Angioedema; Bradykinin-mediated; Emergency department; Guideline; Histamine-mediated;
D O I：
10.1186/s12245-017-0141-z
中图分类号：
学科分类号：
摘要：
Background: Angioedema is a common presentation in the emergency department (ED). Airway angioedema can be fatal; therefore, prompt diagnosis and correct treatment are vital. Objective of the review: Based on the findings of two expert panels attended by international experts in angioedema and emergency medicine, this review aims to provide practical guidance on the diagnosis, differentiation, and management of histamine- and bradykinin-mediated angioedema in the ED. Review: The most common pathophysiology underlying angioedema is mediated by histamine; however, ED staff must be alert for the less common bradykinin-mediated forms of angioedema. Crucially, bradykinin-mediated angioedema does not respond to the same treatment as histamine-mediated angioedema. Bradykinin-mediated angioedema can result from many causes, including hereditary defects in C1 esterase inhibitor (C1-INH), side effects of angiotensin-converting enzyme inhibitors (ACEis), or acquired deficiency in C1-INH. The increased use of ACEis in recent decades has resulted in more frequent encounters with ACEi-induced angioedema in the ED; however, surveys have shown that many ED staff may not know how to recognize or manage bradykinin-mediated angioedema, and hospitals may not have specific medications or protocols in place. Conclusion: ED physicians must be aware of the different pathophysiologic pathways that lead to angioedema in order to efficiently and effectively manage these potentially fatal conditions. © 2017, The Author(s).
引用
收藏
相关论文
共 68 条
  • [1] Bernstein J.A., Moellman J., Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema, Int J Emerg Med, 5, (2012)
  • [2] Kelly M., Donnelly J.P., McAnnally J.R., Wang H.E., National estimates of emergency department visits for angioedema and allergic reactions in the United States, Allergy Asthma Proc, 34, pp. 150-154, (2013)
  • [3] Bernstein J.A., HAE update: epidemiology and burden of disease, Allergy Asthma Proc, 34, pp. 3-6, (2013)
  • [4] Lombardi C., Crivellaro M., Dama A., Senna G., Gargioni S., Passalacqua G., Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors? A questionnaire survey in different medical categories, Chest, 128, pp. 976-979, (2005)
  • [5] Zilberberg M.D., Jacobsen T., Tillotson G., The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007, Allergy Asthma Proc, 31, pp. 511-519, (2010)
  • [6] Zilberberg M.D., Nathanson B.H., Jacobsen T., Tillotson G., Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006–2007, Allergy Asthma Proc, 32, pp. 390-394, (2011)
  • [7] Bertazzoni G., Spina M.T., Scarpellini M.G., Buccelletti F., De Simone M., Gregori M., Et al., Drug-induced angioedema: experience of Italian emergency departments, Intern Emerg Med, 9, pp. 455-462, (2014)
  • [8] Felder S., Curtis R.M., Ball I., Borici-Mazi R., Prognostic factors in outcome of angioedema in the emergency department, Allergy Asthma Proc, 35, pp. 362-370, (2014)
  • [9] Jolles S., Williams P., Carne E., Mian H., Huissoon A., Wong G., Et al., A UK national audit of hereditary and acquired angioedema, Clin Exp Immunol, 175, pp. 59-67, (2014)
  • [10] Banerji A., Clark S., Blanda M., LoVecchio F., Snyder B., Camargo C.A., Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department, Ann Allergy Asthma Immunol, 100, pp. 327-332, (2008)
1234567